MPX-10617-23676
3 vaccinations
4 coded responses
22 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 600 / IL
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
-
2021-03-19
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: Good · Fatigue or tirednessFree text: A bit sore at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Sneezing — Feeling: Fair · Fatigue or tirednessFree text: SneezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Fair · Fatigue or tirednessFree text: Running noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-03-24
- 2021-03-26
- 2021-04-02
-
2021-04-07
Dose 2 — Pfizer-BioNTech
-
2021-04-07
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: Good · Site: SwellingFree text:MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-30
- 2021-05-07
- 2021-05-12
- 2021-05-19
- 2021-07-09
- 2021-10-06
-
2021-11-29
Dose 3 — Pfizer-BioNTech
- 2022-04-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-11-29 | Pfizer-BioNTech | No |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): A bit sore at the injection site
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Sneezing
Systemic reaction (other): Running nose
Release 7 — day 0, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release